SANA Insider Trading - Sana Biotechnology, Inc.

Jumlah Saham Beredar	262,060,228 shares
Saham Orang Dalam	93,440,211 shares
Kepemilikan oleh Orang Dalam	35.66 %
Orang Dalam Sejati	22

Skor Sentimen Orang Dalam

Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.

Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan akumulasi orang dalam tertinggi.

Lihat Saham dengan Peringkat Tertinggi

Skor Sentimen Petugas

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.

Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.

Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Setiap Hari

Lihat Pilihan Teratas dari Orang Dalam, yang menyediakan daftar perusahaan dengan sentimen orang dalam tertinggi.

Lihat Saham dengan Peringkat Tertinggi

Metrik Utama Orang Dalam

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).

Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)

0 ( )

5746 out of 11305

Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).

Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)

0.000 %( )

5702 out of 11224

Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.

Grafik Perdagangan Orang Dalam

Grafik berikut menunjukkan Sana Biotechnology, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.

Daftar Orang Dalam dan Metrik Profitabilitas

Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Orang Dalam	Saham Dimiliki	Terbagi Disesuaikan
Noubar Afeyan 10% Owner - [10%]	11,585,199	0
Sunil Agarwal EVP, Head of Development & CMO - [O]	1,550,000	1,550,000
ARCH Venture Fund X, L.P. 10% Owner - [10%]	22,747,272	22,747,272
ARCH Venture Partners X, LLC 10% Owner - [10%]	11,718,750	22,747,272
Bilenker Joshua H. Director - [D]	20,000	20,000
Hans Edgar Bishop Director - [D]	5,828,955	5,828,955
Keith Crandell 10% Owner - [10%]	22,747,272	22,747,272

Orang Dalam	Saham Dimiliki	Terbagi Disesuaikan
Bernard J Cassidy EVP & General Counsel - [O]	112,990	112,990
FMR LLC / Fidelity Management & Research 10% Owner - [10%]	4,541,572	4,541,572
Flagship Ventures Fund V General Partner LLC 10% Owner - [10%]	22,546,725	0
Flagship Ventures Management, Inc. 10% Owner - [10%]	0	0
Steven Gillis 10% Owner - [10%]	11,718,750	22,747,272
Nathan Hardy SVP, Chief Financial Officer - [O]	511,250	511,250
Steve Harr President & CEO, Director - [D] [O]	7,876,930	7,876,930

Orang Dalam	Saham Dimiliki	Terbagi Disesuaikan
Christian Hordo EVP, Chief Business Officer - [O]	867,455	867,455
MacDonald James J. EVP & General Counsel - [O]	497,396	497,396
Richard Mulligan Director - [D]	2,698,121	2,698,121
Robert Nelsen Director, 10% Owner - [D] [10%]	22,761,125	22,761,125
Mary Agnes Wilderotter Director - [D]	7,106	7,106
Wyrick Susan D. See Remarks - [O]	157,395	157,395
Patrick Y Yang Director - [D]	149,250	149,250
Maltzahn Geoffrey von Director - [D]	366,122	366,122

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di SANA / Sana Biotechnology, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan	Orang Dalam	Dilaporkan Saham	Dilaporkan Harga	Disesuaikan Saham	Disesuaikan Harga	Dasar Biaya	Hari-hari menuju Maksimal	Harga di Maksimal	Maksimal Keuntungan ($)	Maksimum Pengembalian (%)
2024-02-08	ARCH Venture Fund X, L.P.	727,272	5.5000	727,272	5.5000	3,999,996	22	11.2700	4,196,359	104.91
2024-02-08	ARCH Venture Fund X, L.P.	363,637	5.5000	363,637	5.5000	2,000,004
2024-02-08	ARCH Venture Fund X, L.P.	727,272	5.5000	727,272	5.5000	3,999,996
2022-03-21	Yang Patrick Y	28,000	7.3000	28,000	7.3000	204,400
2021-02-03	Bilenker Joshua H.	20,000	25.0000	20,000	25.0000	500,000

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

SANA / Sana Biotechnology, Inc. Insider Trades

Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek

Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di SANA / Sana Biotechnology, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan	Orang Dalam	Dilaporkan Saham	Dilaporkan Harga	Disesuaikan Saham	Disesuaikan Harga	Dasar Biaya	Hari-hari menuju Menit	Harga di Menit	Kerugian Maksimal Dihindari ($)	Kerugian Maksimal Dihindari (%)
2025-01-08	FMR LLC / Fidelity Management & Research	100,000	6.1100	100,000	6.1100	611,000	90	1.3400	-477,000	-78.07
2025-01-08	FMR LLC / Fidelity Management & Research	25,000	6.5000	25,000	6.5000	162,500
2025-01-08	FMR LLC / Fidelity Management & Research	164,912	6.7100	164,912	6.7100	1,106,560
2025-01-08	FMR LLC / Fidelity Management & Research	1,000	7.2600	1,000	7.2600	7,260
2024-03-08	Yang Patrick Y	25,000	9.4520	25,000	9.4520	236,300
2023-06-07	Flagship Ventures Fund V General Partner LLC	177,240	6.2397	177,240	6.2397	1,105,924
2023-06-07	Flagship Ventures Fund V General Partner LLC	22,760	6.2397	22,760	6.2397	142,016
2023-06-06	Flagship Ventures Fund V General Partner LLC	181,461	6.3061	181,461	6.3061	1,144,311
2023-06-06	Flagship Ventures Fund V General Partner LLC	22,297	6.3061	22,297	6.3061	140,607

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).

Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.

Berkas Tanggal	Perdagangan Tanggal	Formulir	Orang Dalam	Ticker	Judul Keamanan	Kode	Langsung	Latihan Harga	Satuan Harga	Unit Diubah	Nilai Diubah (1 ribu)	Sisa Pilihan	Sisa Saham
2025-07-08	2025-07-07	4	Bishop Hans Edgar	SANA	Common Stock	A - Award	D			7,842			5,828,955
2025-04-08	2025-04-07	4	Bishop Hans Edgar	SANA	Common Stock	A - Award	D			16,339			5,821,113
2025-03-10	2025-03-10	4	Harr Steve	SANA	Common Stock	F - Taxes	D		2.5600	-12,820	-33		7,876,930
2025-03-10	2025-03-07	4	Harr Steve	SANA	Common Stock	M - Exercise	D			50,000			7,889,750
2025-03-10	2025-03-10	4	Cassidy Bernard J	SANA	Common Stock	F - Taxes	D		2.5600	-2,833	-7		112,990
2025-03-10	2025-03-07	4	Cassidy Bernard J	SANA	Common Stock	M - Exercise	D			11,041			115,823
2025-03-10	2025-03-10	4	Wyrick Susan D.	SANA	Common Stock	F - Taxes	D		2.5600	-836	-2		157,395
2025-03-10	2025-03-07	4	Wyrick Susan D.	SANA	Common Stock	M - Exercise	D			3,250			158,231
2025-03-03	2025-03-03	4	Wyrick Susan D.	SANA	Common Stock	F - Taxes	D		2.5600	-490	-1		154,981
2025-03-03	2025-03-02	4	Wyrick Susan D.	SANA	Common Stock	M - Exercise	D			1,525			155,471
2025-01-10	2025-01-08	4	FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP	SANA	Common Stock	S - Sale	I		7.2600	-1,000	-7		4,541,511
2025-01-10	2025-01-08	4	FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP	SANA	Common Stock	S - Sale	I		6.7100	-164,912	-1,107		4,542,511
2025-01-10	2025-01-08	4	FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP	SANA	Common Stock	S - Sale	I		6.5000	-25,000	-162		4,707,423
2025-01-10	2025-01-08	4	FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP	SANA	Common Stock	S - Sale	I		6.1100	-100,000	-611		4,732,423
2025-01-07	2025-01-06	4	Bishop Hans Edgar	SANA	Common Stock	A - Award	D			14,285			5,804,774
2025-01-03	2025-01-02	4	Wyrick Susan D.	SANA	Common Stock	F - Taxes	D		1.6500	-1,566	-3		153,946
2025-01-03	2025-01-02	4	Wyrick Susan D.	SANA	Common Stock	M - Exercise	D			5,000			155,512
2024-11-21		3/A	FMR LLC / Fidelity Management & Research FMR Capital, Inc.	SANA	Common Stock		I						61
2024-10-15		3	Wyrick Susan D.	SANA	Common Stock		D						147,512
2024-10-09	2024-10-07	4	Bishop Hans Edgar	SANA	Common Stock	A - Award	D			5,938			5,790,489
2024-09-26	2024-09-25	4	Mulligan Richard	SANA	Common Stock	S - Sale	D		3.8878	-150,000	-583		2,698,121
2024-09-26	2024-09-24	4	Mulligan Richard	SANA	Common Stock	S - Sale	D		4.0838	-150,000	-613		2,848,121
2024-07-08	2024-07-05	4	Bishop Hans Edgar	SANA	Common Stock	A - Award	D			4,911			5,784,551
2024-04-08	2024-04-05	4	Bishop Hans Edgar	SANA	Common Stock	A - Award	D			2,774			5,779,640
2024-04-08		3	FMR LLC / Fidelity Management & Research F-Prime Capital Partners Life Sciences Fund VI LP	SANA	Common Stock		I						4,832,423
2024-03-11	2024-03-08	4	Yang Patrick Y	SANA	Common Stock	S - Sale	D		9.4520	-25,000	-236		149,250
2024-02-12	2024-02-08	4	NELSEN ROBERT	SANA	Common Stock	P - Purchase	I		5.5000	727,272	4,000		12,446,022
2024-02-12	2024-02-08	4	NELSEN ROBERT	SANA	Common Stock	P - Purchase	I		5.5000	727,272	4,000		12,446,022
2024-02-12	2024-02-08	4	NELSEN ROBERT	SANA	Common Stock	P - Purchase	I		5.5000	363,637	2,000		10,667,387
2024-02-12	2024-02-08	4	CRANDELL KEITH	SANA	Common Stock	P - Purchase	I		5.5000	727,272	4,000		12,446,022
2024-02-12	2024-02-08	4	CRANDELL KEITH	SANA	Common Stock	P - Purchase	I		5.5000	727,272	4,000		12,446,022
2024-02-12	2024-02-08	4	CRANDELL KEITH	SANA	Common Stock	P - Purchase	I		5.5000	363,637	2,000		10,667,387
2024-02-12	2024-02-08	4	ARCH Venture Fund X, L.P.	SANA	Common Stock	P - Purchase	I		5.5000	727,272	4,000		12,446,022
2024-02-12	2024-02-08	4	ARCH Venture Fund X, L.P.	SANA	Common Stock	P - Purchase	I		5.5000	727,272	4,000		12,446,022
2024-02-12	2024-02-08	4	ARCH Venture Fund X, L.P.	SANA	Common Stock	P - Purchase	I		5.5000	363,637	2,000		10,667,387
2024-01-08	2024-01-05	4	Wilderotter Mary Agnes	SANA	Common Stock	A - Award	D			1,470			7,106
2024-01-08	2024-01-05	4	Bishop Hans Edgar	SANA	Common Stock	A - Award	D			4,901			5,776,866
2023-12-18	2023-12-15	4	Hordo Christian	SANA	Common Stock	S - Sale	D		4.0013	-75,000	-300		867,455
2023-10-06	2023-10-05	4	Bishop Hans Edgar	SANA	Common Stock	A - Award	D			6,925			5,771,965
2023-10-06	2023-10-05	4	Wilderotter Mary Agnes	SANA	Common Stock	A - Award	D			2,077			5,636
2023-09-15	2023-09-13	4	Flagship Ventures Management, Inc. By Flagship Pioneering Fund VI General Partner LLC	SANA	Common Stock	J - Other	I			-70,813			0
2023-09-15	2023-09-13	4	Flagship Ventures Management, Inc. By Flagship Pioneering Fund VI, L.P.	SANA	Common Stock	J - Other	I			-2,431,281			7,293,841
2023-09-15	2023-09-13	4	Flagship Ventures Management, Inc. By Flagship Ventures Fund V General Partner LLC	SANA	Common Stock	J - Other	I			-1,181,745			0
2023-09-15	2023-09-13	4	Flagship Ventures Management, Inc. By Flagship V VentureLabs Rx Fund, L.P.	SANA	Common Stock	J - Other	I			-345,069			1,035,208
2023-09-15	2023-09-13	4	Flagship Ventures Management, Inc. By Flagship Ventures Fund V, L.P.	SANA	Common Stock	J - Other	I			-4,926,378			8,057,470
2023-09-15	2023-09-13	4	Flagship Ventures Management, Inc. By Flagship VentureLabs V, LLC	SANA	Common Stock	J - Other	I			-2,825,989			8,615,337
2023-07-06	2023-07-05	4	Wilderotter Mary Agnes	SANA	Common Stock	A - Award	D			1,245			3,559
2023-07-06	2023-07-05	4	Bishop Hans Edgar	SANA	Common Stock	A - Award	D			4,152			5,765,040
2023-06-08	2023-06-07	4	Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P.	SANA	Common Stock	S - Sale	I		6.2397	-22,760	-142		1,380,277
2023-06-08	2023-06-07	4	Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P.	SANA	Common Stock	S - Sale	I		6.2397	-177,240	-1,106		10,743,293
2023-06-08	2023-06-06	4	Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P.	SANA	Common Stock	S - Sale	I		6.3061	-22,297	-141		1,403,037
2023-06-08	2023-06-06	4	Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P.	SANA	Common Stock	S - Sale	I		6.3061	-181,461	-1,144		10,920,533
2023-05-26	2023-05-26	4	Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P.	SANA	Common Stock	S - Sale	I		6.2265	-9,330	-58		1,425,334
2023-05-26	2023-05-26	4	Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P.	SANA	Common Stock	S - Sale	I		6.2265	-72,670	-452		11,101,994
2023-05-26	2023-05-25	4	Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P.	SANA	Common Stock	S - Sale	I		6.3522	-13,127	-83		1,434,664
2023-05-26	2023-05-25	4	Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P.	SANA	Common Stock	S - Sale	I		6.3522	-102,245	-649		11,174,664
2023-05-26	2023-05-24	4	Flagship Ventures Fund V General Partner LLC By Flagship V VentureLabs Rx Fund, L.P.	SANA	Common Stock	S - Sale	I		6.5652	-39,580	-260		1,447,791
2023-05-26	2023-05-24	4	Flagship Ventures Fund V General Partner LLC By Flagship Ventures Fund V, L.P.	SANA	Common Stock	S - Sale	I		6.5652	-308,290	-2,024		11,276,909
2023-04-06	2023-04-05	4	Bishop Hans Edgar	SANA	Common Stock	A - Award	D			7,716			5,760,888
2023-04-06	2023-04-05	4	Wilderotter Mary Agnes	SANA	Common Stock	A - Award	D			2,314			2,314
2023-02-17	2021-02-03	4	Bilenker Joshua H.	SANA	Common Stock	P - Purchase	D		25.0000	20,000	500		20,000
2023-01-06	2023-01-05	4	Bishop Hans Edgar	SANA	Common Stock	A - Award	D			6,702			5,753,172
2023-01-06	2023-01-05	4	NELSEN ROBERT	SANA	Common Stock	A - Award	D			536			1,353
2022-10-06	2022-10-05	4	NELSEN ROBERT	SANA	Common Stock	A - Award	D			321			817
2022-10-06	2022-10-05	4	Bishop Hans Edgar	SANA	Common Stock	A - Award	D			4,012			5,746,470
2022-09-20		3/A	Cassidy Bernard J	SANA	Common Stock		D						92,781
2022-09-16		3	Cassidy Bernard J	SANA	Common Stock		D						82,031
2022-07-07	2022-07-05	4	Bishop Hans Edgar	SANA	Common Stock	A - Award	D			3,328			5,742,458
2022-07-07	2022-07-05	4	NELSEN ROBERT	SANA	Common Stock	A - Award	D			266			496
2022-06-15	2022-06-13	4	MacDonald James J.	SANA	Common Stock	M - Exercise	D		1.4800	66,796	99		497,396
2022-06-15	2022-05-13	4	MacDonald James J.	SANA	Common Stock	A - Award	D		4.2840	1,183	5		430,600
2022-04-15	2021-04-14	4	Harr Steve	SANA	Common Stock	G - Gift	D			-167,000			7,839,750
2022-04-15	2021-04-14	4	Harr Steve	SANA	Common Stock	G - Gift	D			-167,000			7,839,750
2022-04-06	2022-04-05	4	Bishop Hans Edgar	SANA	Common Stock	A - Award	D			2,880			5,739,130
2022-04-06	2022-04-05	4	NELSEN ROBERT	SANA	Common Stock	A - Award	D			230			230
2022-03-22	2022-03-21	4	Yang Patrick Y	SANA	Common Stock	P - Purchase	D		7.3000	28,000	204		174,250
2022-03-08	2022-03-03	4	Harr Steve	SANA	Stock Options (Right to Buy)	A - Award	D	5.70		760,000		760,000
2022-03-08	2022-03-03	4	AGARWAL SUNIL	SANA	Stock Options (Right to Buy)	A - Award	D	5.70		250,000		250,000
2022-03-08	2022-03-03	4	Mulligan Richard	SANA	Stock Options (Right to Buy)	A - Award	D	5.70		250,000		250,000
2022-03-08	2022-03-03	4	Hordo Christian	SANA	Stock Options (Right to Buy)	A - Award	D	5.70		225,000		225,000
2022-03-08	2022-03-03	4	MacDonald James J.	SANA	Stock Options (Right to Buy)	A - Award	D	5.70		225,000		225,000
2022-03-08	2022-03-03	4	Hardy Nathan	SANA	Stock Options (Right to Buy)	A - Award	D	5.70		225,000		225,000
2022-02-23	2022-02-18	4	MacDonald James J.	SANA	Common Stock	S - Sale	D		6.2800	-333	-2		429,417
2022-02-23	2021-11-15	4	MacDonald James J.	SANA	Common Stock	A - Award	D		18.2325	1,000	18		429,750
2021-09-17	2021-09-16	4	AGARWAL SUNIL	SANA	Common Stock	S - Sale	D		26.0000	-1,627	-42		1,550,000
2021-09-17	2021-09-15	4	AGARWAL SUNIL	SANA	Common Stock	S - Sale	D		26.0695	-58,373	-1,522		1,551,627
2021-09-14	2021-09-10	4	Hordo Christian	SANA	Common Stock	S - Sale	D		25.0000	-1,477	-37		942,455
2021-09-10	2021-09-09	4	Hordo Christian	SANA	Stock Option (Right to Buy)	M - Exercise	D	1.48		-39,205		88,803
2021-09-10	2021-09-09	4	Hordo Christian	SANA	Common Stock	S - Sale	D		25.0081	-25,466	-637		943,932
2021-09-10	2021-09-09	4	Hordo Christian	SANA	Common Stock	S - Sale	D		25.0130	-39,205	-981		969,398
2021-09-10	2021-09-09	4	Hordo Christian	SANA	Common Stock	M - Exercise	D		1.4800	39,205	58		1,008,603
2021-09-07	2021-09-03	4	Hordo Christian	SANA	Stock Option (Right to Buy)	M - Exercise	D	1.48		-700		128,008
2021-09-07	2021-09-03	4	Hordo Christian	SANA	Common Stock	S - Sale	D		25.0000	-700	-18		969,398
2021-09-07	2021-09-03	4	Hordo Christian	SANA	Common Stock	M - Exercise	D		1.4800	700	1		970,098
2021-09-07	2021-09-02	4	Hordo Christian	SANA	Stock Option (Right to Buy)	M - Exercise	D	1.48		-6,558		128,708
2021-09-07	2021-09-02	4	Hordo Christian	SANA	Common Stock	S - Sale	D		25.0039	-1,400	-35		969,398
2021-09-07	2021-09-02	4	Hordo Christian	SANA	Common Stock	S - Sale	D		25.0019	-6,558	-164		970,798
2021-09-07	2021-09-02	4	Hordo Christian	SANA	Common Stock	M - Exercise	D		1.4800	6,558	10		977,356
2021-09-03	2021-09-01	4	Hordo Christian	SANA	Stock Option (Right to Buy)	M - Exercise	D	1.48		-1,134		135,266
2021-09-03	2021-09-01	4	Hordo Christian	SANA	Common Stock	S - Sale	D		25.0057	-3,002	-75		970,798
2021-09-03	2021-09-01	4	Hordo Christian	SANA	Common Stock	S - Sale	D		25.0036	-1,134	-28		973,800
2021-09-03	2021-09-01	4	Hordo Christian	SANA	Common Stock	M - Exercise	D		1.4800	1,134	2		974,934
2021-09-01	2021-08-30	4	Hordo Christian	SANA	Stock Option (Right to Buy)	M - Exercise	D	1.48		-1,100		136,400
2021-09-01	2021-08-30	4	Hordo Christian	SANA	Common Stock	S - Sale	D		25.0183	-1,200	-30		973,800
2021-09-01	2021-08-30	4	Hordo Christian	SANA	Common Stock	S - Sale	D		25.0100	-1,100	-28		975,000
2021-09-01	2021-08-30	4	Hordo Christian	SANA	Common Stock	M - Exercise	D		1.4800	1,100	2		976,100
2021-04-27	2021-04-21	4	NELSEN ROBERT	SANA	Common Stock	J - Other	I			12,500			12,500
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series B Convertible Preferred Stock	C - Conversion	I			-2,343,750		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series B Convertible Preferred Stock	C - Conversion	I			-2,343,750		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series B Convertible Preferred Stock	C - Conversion	I			-781,250		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series B Convertible Preferred Stock	C - Conversion	I			-781,250		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-5,687,500		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-5,687,500		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-9,375,000		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-9,375,000		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series A-1 Convertible Preferred Stock	C - Conversion	I			-3,687,500		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series A-1 Convertible Preferred Stock	C - Conversion	I			-3,687,500		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Common Stock	C - Conversion	I			11,718,750			11,718,750
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Common Stock	C - Conversion	I			11,718,750			11,718,750
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Common Stock	C - Conversion	I			10,156,250			10,301,250
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Common Stock	C - Conversion	I			10,156,250			10,301,250
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series B Convertible Preferred Stock	C - Conversion	I			-2,343,750		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series B Convertible Preferred Stock	C - Conversion	I			-2,343,750		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series B Convertible Preferred Stock	C - Conversion	I			-781,250		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series B Convertible Preferred Stock	C - Conversion	I			-781,250		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-5,687,500		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-5,687,500		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-9,375,000		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-9,375,000		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series A-1 Convertible Preferred Stock	C - Conversion	I			-3,687,500		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Series A-1 Convertible Preferred Stock	C - Conversion	I			-3,687,500		0
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Common Stock	C - Conversion	I			11,718,750			11,718,750
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Common Stock	C - Conversion	I			11,718,750			11,718,750
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Common Stock	C - Conversion	I			10,156,250			10,301,250
2021-02-10	2021-02-08	4	ARCH Venture Fund X, L.P. See Footnotes	SANA	Common Stock	C - Conversion	I			10,156,250			10,301,250
2021-02-10	2021-02-08	4	Flagship Ventures Fund V General Partner LLC See footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-11,585,199		0
2021-02-10	2021-02-08	4	Flagship Ventures Fund V General Partner LLC See footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-11,441,326		0
2021-02-10	2021-02-08	4	Flagship Ventures Fund V General Partner LLC See footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-9,725,122		0
2021-02-10	2021-02-08	4	Flagship Ventures Fund V General Partner LLC See footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-1,487,371		0
2021-02-10	2021-02-08	4	Flagship Ventures Fund V General Partner LLC See footnotes	SANA	Common Stock	C - Conversion	I			11,585,199			11,585,199
2021-02-10	2021-02-08	4	Flagship Ventures Fund V General Partner LLC See footnotes	SANA	Common Stock	C - Conversion	I			11,441,326			11,441,326
2021-02-10	2021-02-08	4	Flagship Ventures Fund V General Partner LLC See footnotes	SANA	Common Stock	C - Conversion	I			9,725,122			9,725,122
2021-02-10	2021-02-08	4	Flagship Ventures Fund V General Partner LLC See footnotes	SANA	Common Stock	C - Conversion	I			1,487,371			1,487,371
2021-02-10	2021-02-08	4	Bishop Hans Edgar	SANA	Series B Convertible Preferred Stock	C - Conversion	D			-156,250		0
2021-02-10	2021-02-08	4	Bishop Hans Edgar	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	D			-800,000		0
2021-02-10	2021-02-08	4	Bishop Hans Edgar	SANA	Series A-1 Convertible Preferred Stock	C - Conversion	D			-1,075,000		0
2021-02-10	2021-02-08	4	Bishop Hans Edgar	SANA	Common Stock	C - Conversion	D			2,031,250			5,736,250
2021-02-10	2021-02-08	4	NELSEN ROBERT See Footnotes	SANA	Series B Convertible Preferred Stock	C - Conversion	I			-2,343,750		0
2021-02-10	2021-02-08	4	NELSEN ROBERT See Footnotes	SANA	Series B Convertible Preferred Stock	C - Conversion	I			-2,343,750		0
2021-02-10	2021-02-08	4	NELSEN ROBERT See Footnotes	SANA	Series B Convertible Preferred Stock	C - Conversion	I			-781,250		0
2021-02-10	2021-02-08	4	NELSEN ROBERT See Footnotes	SANA	Series B Convertible Preferred Stock	C - Conversion	I			-781,250		0
2021-02-10	2021-02-08	4	NELSEN ROBERT See Footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-5,687,500		0
2021-02-10	2021-02-08	4	NELSEN ROBERT See Footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-5,687,500		0
2021-02-10	2021-02-08	4	NELSEN ROBERT See Footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-9,375,000		0
2021-02-10	2021-02-08	4	NELSEN ROBERT See Footnotes	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-9,375,000		0
2021-02-10	2021-02-08	4	NELSEN ROBERT See Footnotes	SANA	Series A-1 Convertible Preferred Stock	C - Conversion	I			-3,687,500		0
2021-02-10	2021-02-08	4	NELSEN ROBERT See Footnotes	SANA	Series A-1 Convertible Preferred Stock	C - Conversion	I			-3,687,500		0
2021-02-10	2021-02-08	4	NELSEN ROBERT See Footnotes	SANA	Common Stock	C - Conversion	I			11,718,750			11,718,750
2021-02-10	2021-02-08	4	NELSEN ROBERT See Footnotes	SANA	Common Stock	C - Conversion	I			11,718,750			11,718,750
2021-02-10	2021-02-08	4	NELSEN ROBERT See Footnotes	SANA	Common Stock	C - Conversion	I			10,156,250			10,301,250
2021-02-10	2021-02-08	4	NELSEN ROBERT See Footnotes	SANA	Common Stock	C - Conversion	I			10,156,250			10,301,250
2021-02-10	2021-02-08	4	von Maltzahn Geoffrey Held by the Geoffrey A. von Malzahn 2020 GRAT	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	I			-366,122		0
2021-02-10	2021-02-08	4	von Maltzahn Geoffrey	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	D			-1,464,488		0
2021-02-10	2021-02-08	4	von Maltzahn Geoffrey Held by the Geoffrey A. von Malzahn 2020 GRAT	SANA	Common Stock	C - Conversion	I			366,122			366,122
2021-02-10	2021-02-08	4	von Maltzahn Geoffrey	SANA	Common Stock	C - Conversion	D			1,464,488			1,464,488
2021-02-10	2021-02-08	4	Harr Steve	SANA	Series B Convertible Preferred Stock	C - Conversion	D			-156,250		0
2021-02-10	2021-02-08	4	Harr Steve	SANA	Series A-2 Convertible Preferred Stock	C - Conversion	D			-800,000		0
2021-02-10	2021-02-08	4	Harr Steve	SANA	Series A-1 Convertible Preferred Stock	C - Conversion	D			-1,075,000		0
2021-02-10	2021-02-08	4	Harr Steve	SANA	Common Stock	C - Conversion	D			2,031,250			8,173,750
2021-02-10	2021-02-08	4	MacDonald James J. Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10	SANA	Series B Convertible Preferred Stock	C - Conversion	I			-7,812		0
2021-02-10	2021-02-08	4	MacDonald James J.	SANA	Series A-1 Convertible Preferred Stock	C - Conversion	D			-93,750		0
2021-02-10	2021-02-08	4	MacDonald James J. Held by The James J. MacDonald and Rena Chng Trust dtd 01/15/10	SANA	Common Stock	C - Conversion	I			7,812			7,812
2021-02-10	2021-02-08	4	MacDonald James J.	SANA	Common Stock	C - Conversion	D			93,750			428,750
2021-02-05	2021-02-03	4	NELSEN ROBERT	SANA	Stock Option (Right to Buy)	A - Award	D	25.00		14,000		14,000
2021-02-05	2021-02-03	4	von Maltzahn Geoffrey	SANA	Stock Option (Right to Buy)	A - Award	D	25.00		14,000		14,000
2021-02-05	2021-02-03	4	Bishop Hans Edgar	SANA	Stock Option (Right to Buy)	A - Award	D	25.00		14,000		14,000
2021-02-05	2021-02-03	4	AGARWAL SUNIL	SANA	Stock Option (Right to Buy)	A - Award	D	25.00		48,000		48,000
2021-02-05	2021-02-03	4	Bilenker Joshua H.	SANA	Stock Option (Right to Buy)	A - Award	D	25.00		7,000		7,000
2021-02-05	2021-02-03	4	Cole Douglas G.	SANA	Stock Option (Right to Buy)	A - Award	D	25.00		14,000		14,000
2021-02-05	2021-02-03	4	Wilderotter Mary Agnes	SANA	Stock Option (Right to Buy)	A - Award	D	25.00		14,000		14,000
2021-02-05	2021-02-03	4	Seitz Michelle	SANA	Stock Option (Right to Buy)	A - Award	D	25.00		7,000		7,000
2021-02-05	2021-02-03	4	Yang Patrick Y	SANA	Stock Option (Right to Buy)	A - Award	D	25.00		14,000		14,000
2021-02-05	2021-02-03	4	REICIN ALISE	SANA	Stock Option (Right to Buy)	A - Award	D	25.00		7,000		7,000
2021-02-03		3	AGARWAL SUNIL	SANA	Common Stock		D						1,610,000
2021-02-03		3	NELSEN ROBERT See Footnotes	SANA	Common Stock		I						145,000
2021-02-03		3	NELSEN ROBERT See Footnotes	SANA	Common Stock		I						147,500
2021-02-03		3	GILLIS STEVEN See Footnotes	SANA	Common Stock		I						147,500
2021-02-03		3	GILLIS STEVEN See Footnotes	SANA	Common Stock		I						145,000
2021-02-03		3	ARCH Venture Partners X, LLC See Footnotes	SANA	Common Stock		I						147,500
2021-02-03		3	ARCH Venture Partners X, LLC See Footnotes	SANA	Common Stock		I						145,000
2021-02-03		3	Hordo Christian	SANA	Common Stock		D						975,000
2021-02-03		3	Yang Patrick Y	SANA	Common Stock		D						146,250
2021-02-03		3	MacDonald James J.	SANA	Common Stock		D						335,000
2021-02-03		3	MacDonald James J. Held by the KOM Trust	SANA	Common Stock		I						125,000
2021-02-03		3	MacDonald James J. Held by the NMM Trust	SANA	Common Stock		I						125,000
2021-02-03		3	Mulligan Richard	SANA	Common Stock		D						2,998,121
2021-02-03		3	Harr Steve	SANA	Common Stock		D						6,142,500
2021-02-03		3	Harr Steve Held by Harr Family Irrevocable Trust of 2015 dtd 12/28/2015	SANA	Common Stock		I						682,500
2021-02-03		3	Bishop Hans Edgar	SANA	Common Stock		D						3,705,000
2021-02-03		3	Hardy Nathan	SANA	Common Stock		D						511,250

Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.

Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.

Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)

Konversi turunan

Penjualan atau pengalihan sekuritas kembali ke perusahaan.

Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.

Pemberian sekuritas oleh atau kepada orang dalam.

Swap ekuitas dan transaksi lindung nilai serupa

Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)

Transaksi yang dilaporkan secara sukarela pada Formulir 4.

Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)

SANA / Sana Biotechnology, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5